Electromagnetic signal delivery for tissue affected by neuronal dysfunction, degradation, damage, and/or necrosis, and associated systems and methods

• US 7,949,401 B2
• Filed: 04/06/2007
• Issued: 05/24/2011
• Est. Priority Date: 04/11/2006
• Status: Expired due to Fees

• Current Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Inventors: Fowler, Brad, Himes, David, Gliner, Bradford E.
• Primary Examiner(s): Layno; Carl H
• Assistant Examiner(s): MALAMUD, DEBORAH LESLIE
• Application Number:
  US11/697,694
• Publication Number:
  US 20080039895A1
• Time in Patent Office: 1,509 Days
• Field of Search: 600/9, 600/13, 600/544, 607 1- 2, 607/45
• US Class Current: 607/45
• CPC Class Codes: A61N 1/36017 with leads or electrodes penetrating the skin
• CPC Class Codes: A61N 1/36025 for treating a mental or cerebral condition
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
• CPC Class Codes: A61N 2/006 for magnetic stimulation of nerve tissue

Abstract

Electromagnetic signal delivery for tissue affected by neuronal dysfunction, degradation, damage, and/or necrosis, and associated systems and methods are disclosed. A method in accordance with one embodiment of the invention includes identifying an affected region, with the affected region including neuronal tissue that, at least during a pre-dysfunctional period, was in neural communication with neuronal tissue in a dysfunctional region. The affected tissue can be functionally adversely affected by neuronal dysfunction in the dysfunctional region. The method can further include applying electromagnetic signals to the neuronal tissue in the affected region. For example, the electromagnetic signals can be applied to a hypo-active neural region that is not physically damaged, and has been identified as likely to recover at least in part as a result of electromagnetic signals. Signals can be applied at sub-threshold levels to cortical and/or subcortical regions.

Claims

1. A method for treating neuronal tissue of a patient using electrical stimulation, comprising:

identifying a location of an infarct region having dysfunctional neuronal tissue that was subjected to a reduced oxygen supply;

based at least in part on the location of the infarct region, identifying an affected region having low morbidity tissue, the affected region including neuronal tissue that, at least during a pre-infarct period, was in neural communication with the dysfunctional neuronal tissue in the infarct region, wherein neuronal tissue in the affected region has reduced neural signal transmission as a result of tissue loss at the infarct region;

implanting at least one electrode at least on, near or adjacent the affected region;

selecting a first set of stimulation parameters such that the neuronal tissue in the affected region is stimulated during a post-acute, pre-chronic period relative to the onset of damage to the low-morbidity neuronal tissue in the affected region; and

selecting a second set of stimulation parameters such that the neuronal tissue in the affected region is stimulated during a chronic period once the onset of damage to the low-morbidity neuronal tissue has occurred; and

controlling a pulse generator to generate electrical pulses and to apply electrical pulses to the patient through the electrode according to the first and second set of stimulation parameters.

2. The method of claim 1 further comprising directing the patient to engage in adjunctive therapy during the chronic period.

3. The method of claim 1 wherein the post-acute, pre-chronic period comprises the period of approximately two weeks after the infarct to about 6 to 12 weeks post-infarct.

4. The method of claim 1 wherein identifying the affected region includes using a diffusion tensor imaging technique.

5. The method of claim 1 wherein the dysfunctional region is a cortical region and wherein identifying the affected region includes identifying a subcortical affected region.

6. The method of claim 1 wherein the dysfunctional region is subcortical region and wherein identifying the affected region includes identifying a cortical affected region.

7. The method of claim 1 further comprising not applying electrical signals to neuronal cells of the affected region having hyperactive spontaneous electrical activity levels.

8. The method of claim 1 further comprising preferentially applying electrical signals to neuronal cells of the affected region having hypoactive spontaneous electrical activity levels.

9. The method of claim 1 further comprising:

preferentially applying electrical signals to first neuronal cells of the affected region having hypoactive spontaneous electrical activity levels;

not applying electrical signals to second neuronal cells of the affected region having hyperactive spontaneous electrical activity levels; and

after spontaneous electrical activity levels of the second neuronal cells become hypoactive, applying electrical signals to the second neuronal cells.

10. The method of claim 1 further comprising:

re-evaluating neural activity of the affected region after the electrical signals via the first set of stimulation parameters;

detecting a shift in the neural activity; and

updating at least one parameter in the first set of stimulation parameters.

11. The method of claim 1 further comprising:

re-evaluating neural activity of the affected region after the electrical signals via the second set of stimulation parameters;

detecting a shift in the neural activity; and

updating at least one parameter in the second set of stimulation parameters.

12. The method of claim 1 wherein the electrodes of an electrode array are positioned on or in the low morbidity tissue region.

13. A method for treating neuronal tissue of a patient using electrical stimulation, comprising:

identifying a location of an infarct region having dysfunctional neuronal tissue that was subjected to a reduced oxygen supply;

based at least in part on the location of the infarct region, identifying an affected region having low morbidity tissue, the affected region including neuronal tissue that, at least during a pre-infarct period, was in neural communication with the dysfunctional neuronal tissue in the infarct region, wherein neuronal tissue in the affected region has reduced neural signal transmission as a result of tissue loss at the infarct region;

positioning at least one electrode at least on, near or adjacent the affected region;

controlling a pulse generator to generate electrical pulses and to apply electrical pulses to the patient through the electrode according to a set of stimulation parameters comprising a first set of stimulation parameters such that the neuronal tissue in the affected region is stimulated during a post-acute, pre-chronic period relative to the onset of damage to the low-morbidity neuronal tissue in the affected region;

a second set of stimulation parameters such that the neuronal tissue in the affected region is stimulated during a chronic period once the onset of damage to the low-morbidity neuronal tissue has occurred or a combination of the first and second set of stimulation parameters;

identifying the onset of a chronic period relative to the occurrence of damage to the neuronal tissue; and

directing the patient to engage in adjunctive therapy during the chronic period.